The Comparative Study Between Bowel Preparation Method (CSBPM)

Inje University

Status and phase

Completed

Phase 3

Conditions

Colonoscopy

Treatments

Drug: Colonoscopy after bowel cleansing

Study type

Interventional

Funder types

Other

Identifiers

NCT01964417

PEG-0488

Details and patient eligibility

About

The purpose of this study is to compare the efficacy, acceptability and preparation-induced mucosal inflammation of PEG + ascorbic acid vs. PEG for colonoscopy.

Full description

This was a prospective randomized single-blinded clinical trial of ambulatory patients to assess the efficacy of bowel preparation and preparation-induced mucosal inflammation.

Endoscopists who were blinded to the preparation taken, assessed both bowel cleansing by using the Ottawa bowel preparation assessment tool and preparation-induced mucosal inflammation. Acceptability was assessed by questionnaire.

Enrollment

319 patients

Sex

All

Ages

20 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients who want colonoscopy purposing screening among adults between the age of 20~65

Exclusion criteria

Under the age of 20, older than 65, pregnant or lactating women, intestinal obstruction, structural intestinal disease, hypothyroidism, gastrointestinal motility, renal failure, congestive heart failure, liver failure, electrolyte abnormalities, who refused research informed consent, inflammatory bowel disease, the obvious symptoms of the disease in patients with lower gastrointestinal (bloody stools, diarrhea, etc.)